227 related articles for article (PubMed ID: 18466421)
1. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
George J; Struthers AD
Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
[TBL] [Abstract][Full Text] [Related]
2. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol treatment reduces arterial wave reflection in stroke survivors.
Khan F; George J; Wong K; McSwiggan S; Struthers AD; Belch JJ
Cardiovasc Ther; 2008; 26(4):247-52. PubMed ID: 19035875
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol as a therapeutic option in cardiovascular disease.
Okafor ON; Farrington K; Gorog DA
Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655
[TBL] [Abstract][Full Text] [Related]
5. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
Harzand A; Tamariz L; Hare JM
Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
[TBL] [Abstract][Full Text] [Related]
6. A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.
Caliceti C; Calabria D; Roda A
Anal Bioanal Chem; 2016 Dec; 408(30):8755-8760. PubMed ID: 27392750
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol as a cardiovascular drug.
Kelkar A; Kuo A; Frishman WH
Cardiol Rev; 2011; 19(6):265-71. PubMed ID: 21983313
[TBL] [Abstract][Full Text] [Related]
8. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
[TBL] [Abstract][Full Text] [Related]
9. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
George J; Struthers AD
Vasc Health Risk Manag; 2009; 5(1):265-72. PubMed ID: 19436671
[TBL] [Abstract][Full Text] [Related]
10. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
[TBL] [Abstract][Full Text] [Related]
11. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
[TBL] [Abstract][Full Text] [Related]
12. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.
Doehner W; Landmesser U
Semin Nephrol; 2011 Sep; 31(5):433-40. PubMed ID: 22000650
[TBL] [Abstract][Full Text] [Related]
13. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
Duan X; Ling F
Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
Kittleson MM; Hare JM
Eur Heart J; 2005 Aug; 26(15):1458-60. PubMed ID: 15917281
[No Abstract] [Full Text] [Related]
15. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction.
Meneshian A; Bulkley GB
Microcirculation; 2002 Jul; 9(3):161-75. PubMed ID: 12080414
[TBL] [Abstract][Full Text] [Related]
16. [Secondary hyperuricemia in hematologic disease].
Inai K; Tsutani H
Nihon Rinsho; 2003 Jan; 61 Suppl 1():299-303. PubMed ID: 12629735
[No Abstract] [Full Text] [Related]
17. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
18. [Xanthine dehydrogenase (xanthine oxidase)].
Ichida K; Yamaguchi Y; Matsumura T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():98-102. PubMed ID: 12629699
[No Abstract] [Full Text] [Related]
19. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
